148 related articles for article (PubMed ID: 22042094)
1. Cyclooxygenase-2 expression in central giant cell lesion of the jaws: an immunohistochemical study.
Nogueira RL; Faria MH; Osterne RL; Cavalcante RB; Ribeiro RA; Rabenhorst SH
J Mol Histol; 2012 Feb; 43(1):59-62. PubMed ID: 22042094
[TBL] [Abstract][Full Text] [Related]
2. FASN expression, angiogenesis and lymphangiogenesis in central and peripheral giant cell lesions.
Falci SG; Mesquita AT; Andrade BA; Miranda JL; Leon JE; Almeida OP; Santos CR
J Appl Oral Sci; 2014 Apr; 22(2):131-7. PubMed ID: 24676584
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of RANKL in oral giant cell lesions is predictive of aggressiveness.
Martini G; Capella D; Rivero ERC; Gondak RO
Braz Oral Res; 2018 Oct; 32():e115. PubMed ID: 30379236
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of TNF-α and TGF-β in central and peripheral giant cell lesions of the jaws.
de Matos FR; de Moraes M; Nonaka CF; de Souza LB; de Almeida Freitas R
J Oral Pathol Med; 2012 Feb; 41(2):194-9. PubMed ID: 21913991
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of matrix metalloproteinase (MMP)-1 and -9 in central giant cell lesions of the jaws: implications for clinical behavior.
Tobón-Arroyave SI; Mideros-Simarra SM; Castaño-Ramírez LM; Flórez-Moreno GA; Isaza-Guzmán DM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):755-63. PubMed ID: 20971661
[TBL] [Abstract][Full Text] [Related]
6. So-called hybrid central odontogenic fibroma/central giant cell lesion of the jaws. A report on seven additional cases, including an example in a patient with cherubism, and hypotheses on the pathogenesis.
Tosios KI; Gopalakrishnan R; Koutlas IG
Head Neck Pathol; 2008 Dec; 2(4):333-8. PubMed ID: 20614305
[TBL] [Abstract][Full Text] [Related]
7. WWOX expression in giant cell lesions of the jaws.
Amaral FR; Diniz MG; Bernardes VF; Souza PE; Gomez RS; Gomes CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):210-3. PubMed ID: 23849374
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Comparative Study of Aggressive and Non-aggressive Central Giant Cell Lesions of the Jaws Based on the Tenascin-C Expression Profile.
Tobón-Arroyave SI; Isaza-Guzmán DM; Flórez-Moreno GA
J Histochem Cytochem; 2021 Jul; 69(7):475-484. PubMed ID: 34120502
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid and calcitonin receptor expression in central giant cell lesions: implications for therapy.
Nogueira RL; Faria MH; Osterne RL; Cavalcante RB; Ribeiro RA; Rabenhorst SH
Int J Oral Maxillofac Surg; 2012 Aug; 41(8):994-1000. PubMed ID: 22365107
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of p53, PCNA, Ki-67, MDM2 and AgNOR in oral peripheral and central giant cell lesions.
Souza PE; Mesquita RA; Gomez RS
Oral Dis; 2000 Jan; 6(1):35-9. PubMed ID: 10673786
[TBL] [Abstract][Full Text] [Related]
11. Quantitative expression analysis of apoptotic/antiapoptotic genes and association with immunolocalization of BAX and BCL-2 in peripheral and central giant cell lesions of the jaws.
Amaral FR; Bernardes VF; Duarte AP; Pereira NB; Vasconcelos AC; Gomez RS; Gomes CC
Tumour Biol; 2011 Oct; 32(5):997-1003. PubMed ID: 21706237
[TBL] [Abstract][Full Text] [Related]
12. NFATc1 and TNFalpha expression in giant cell lesions of the jaws.
Amaral FR; Brito JA; Perdigão PF; Carvalho VM; de Souza PE; Gomez MV; De Marco L; Gomez RS
J Oral Pathol Med; 2010 Mar; 39(3):269-74. PubMed ID: 20002873
[TBL] [Abstract][Full Text] [Related]
13. Immunoexpression of NF-ĸB and their inhibitory subunits IĸBα and IĸBβ in giant cell lesions of the jaws: implications for their clinical behavior.
Tobón-Arroyave SI; Hurtado-García P; García-Quintero OD; Isaza-Guzmán DM; Flórez-Moreno GA
J Oral Pathol Med; 2015 Oct; 44(9):752-60. PubMed ID: 25413222
[TBL] [Abstract][Full Text] [Related]
14. Immunoexpression of Glucose Transporters 1 and 3 and Macrophage Colony-Stimulating Factor in Central and Peripheral Giant Cell Lesions of the Jaws.
Vasconcelos RG; de Matos FR; Vasconcelos MG; da Costa AN; Queiroz LM
J Oral Maxillofac Surg; 2016 May; 74(5):965-72. PubMed ID: 26706492
[TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of calcitonin and glucocorticoid receptors in central giant cell lesions of the jaws.
Batista Severo ML; Lopes MLDS; Miguel MCDC; Germano AR; Nogueira RLM; Turatti E; Cavalcante RB; da Silveira ÉJD
J Oral Pathol Med; 2018 Oct; 47(9):907-913. PubMed ID: 30028524
[TBL] [Abstract][Full Text] [Related]
16. Central giant cell lesion of the jaws: An updated analysis of 2270 cases reported in the literature.
Chrcanovic BR; Gomes CC; Gomez RS
J Oral Pathol Med; 2018 Sep; 47(8):731-739. PubMed ID: 29751369
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Tumor Angiogenesis by Expression of CD 105 in Ameloblastoma, Odontogenic Keratocyst and Central Giant Cell Lesion.
Ali K; Zeb Khan S; Sultana N; Alghamdi O; Muhammad S; Mokeem SA; Ali S; Abduljabbar T; Vohra F
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3373-3379. PubMed ID: 33247698
[TBL] [Abstract][Full Text] [Related]
18. Central giant cell lesion of the jaws: study of CCND1 gene amplification and p16INK4a protein levels.
Nogueira RL; Faria MH; Osterne RL; Cavalcante RB; Ribeiro RA; Nonaka CF; Rabenhorst SH
J Mol Histol; 2013 Oct; 44(5):527-34. PubMed ID: 23504185
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids, calcitonin, and osteocalcin cannot differentiate between aggressive and nonaggressive central giant cell lesions of the jaws.
Martins AF; Souza PO; Rege IC; Morais MO; Mendonça EF
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):386-95. PubMed ID: 26188731
[TBL] [Abstract][Full Text] [Related]
20. The highly prevalent H3F3A mutation in giant cell tumours of bone is not shared by sporadic central giant cell lesion of the jaws.
Gomes CC; Diniz MG; Amaral FR; Antonini Guimarães BV; Gomez RS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Nov; 118(5):583-5. PubMed ID: 25442495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
